1074 related articles for article (PubMed ID: 31587000)
1. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
Guo C; Bai Q; Zhao Z; Zhang J
Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
[TBL] [Abstract][Full Text] [Related]
2. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of fast MRI-based trombolysis in wake-up strokes compared to superacute ischemic strokes within 12 hours.
Bai Q; Zhao Z; Fu P; Sui H; Xie X; Chen J; Yang J
Neurol Res; 2013 Jun; 35(5):492-7. PubMed ID: 23601825
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
[TBL] [Abstract][Full Text] [Related]
5. [Older age is not related to hemorrhagic transformation and favorable outcomes in patients with wake-up ischemic stroke undergoing intravenous thrombolytic therapy].
Zhai LP; Chen ZC; Yan SQ; Zhong GL; Zhang S; Xu MJ; Lou M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 44(6):638-44. PubMed ID: 26822046
[TBL] [Abstract][Full Text] [Related]
6. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
7. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
[TBL] [Abstract][Full Text] [Related]
8. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Thrombolysis Guided by Perfusion CT with Alteplase in >4.5 Hours from Stroke Onset.
Medina-Rodriguez M; Millan-Vazquez M; Zapata-Arriaza E; Escudero I; Pardo-Galiana B; Cabezas-Rodriguez JA; Lebrato-Hernandez L; Ortega-Quintanilla J; de Albóniga-Chindurza A; Ocete-Perez RF; Jurado-Serrano J; Gonzalez-Garcia A; Cayuela A; Moniche F
Cerebrovasc Dis; 2020; 49(3):328-333. PubMed ID: 32615572
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
[TBL] [Abstract][Full Text] [Related]
11. Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan.
Miyamoto Y; Aso S; Iwagami M; Morita K; Fushimi K; Hamasaki Y; Nangaku M; Doi K; Yasunaga H
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105341. PubMed ID: 33039772
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
13. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
Pancioli AM; Adeoye O; Schmit PA; Khoury J; Levine SR; Tomsick TA; Sucharew H; Brooks CE; Crocco TJ; Gutmann L; Hemmen TM; Kasner SE; Kleindorfer D; Knight WA; Martini S; McKinney JS; Meurer WJ; Meyer BC; Schneider A; Scott PA; Starkman S; Warach S; Broderick JP;
Stroke; 2013 Sep; 44(9):2381-7. PubMed ID: 23887841
[TBL] [Abstract][Full Text] [Related]
14. Favourable renal outcomes after intravenous thrombolytic therapy for acute ischemic stroke: Clinical implication of kidney-brain axis.
Chang TH; Chiu PF; Tsai CC; Chang CH; Wu CL; Kor CT; Li JR; Kuo CL; Huang CS; Chu CC; Lin CM; Chang CC
Nephrology (Carlton); 2019 Sep; 24(9):896-903. PubMed ID: 30334303
[TBL] [Abstract][Full Text] [Related]
15. Preprocedure Intravenous Recombinant Tissue Plasminogen Activator and Risk of Distal Embolization with Thrombectomy in Acute Ischemic Stroke.
Qureshi AI; Asif A; Aytac E; Liaqat J; Gurkas E; Lobanova I; Saeed O; Ahsan H; Siddiq F; Gomez CR; French BR
J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104362. PubMed ID: 31562039
[TBL] [Abstract][Full Text] [Related]
16. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
Adeoye O; Knight WA; Khoury J; Schmit PA; Sucharew H; Broderick JP; Pancioli AM;
J Stroke Cerebrovasc Dis; 2014; 23(5):e313-5. PubMed ID: 24534128
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of plasma HMGB1 in ischemic stroke patients with cerebral ischemia-reperfusion injury after intravenous thrombolysis.
Wang J; Jiang Y; Zeng D; Zhou W; Hong X
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105055. PubMed ID: 32807461
[TBL] [Abstract][Full Text] [Related]
18. Should IV Thrombolysis be given in Patients with Suspected Ischemic Stroke but Unknown Symptom Onset and Without Diffusion-Weighted Imaging Lesion? - Results of a Case-Control Study.
Seyhan M; Mackenrodt D; Gunreben I; Müllges W; Haeusler KG; Pham M; Kleinschnitz C; Kraft P
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104515. PubMed ID: 31786042
[TBL] [Abstract][Full Text] [Related]
19. Clinical Deterioration and Early Imaging Changes after Intravenous Tissue Plasminogen Activator Administration in Acute Ischemic Stroke Patients.
Chou C; Bourekas EC; Slivka A
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1823-1827. PubMed ID: 27133771
[TBL] [Abstract][Full Text] [Related]
20. Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset.
Zhao J; Zhao H; Li R; Li J; Liu C; Lv J; Li Y; Liu W; Ma D; Hao H; Xiao X; Liu J; Yin Y; Liu R; Yu Q; Wei Y; Li P; Wang Y; Wang R
Stroke Vasc Neurol; 2019 Mar; 4(1):3-7. PubMed ID: 31105972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
